By Heidi Splete, Practical Pain Manager on July 18, 2023

A secondary analysis of cannabis use by patients with MS, mostly younger individuals with more severe disease progression, shows some pain relief effectiveness.

Nearly one-third of adults with multiple sclerosis report using cannabis for pain management, with oil or tincture being the preferred method of administration, based on data from more than 200 individuals.

Cannabis continues to gain popularity as a pain management option, and its use has extended to patients with multiple sclerosis (MS), but data characterizing the types of cannabis products used and the characteristics of people who use them are lacking, wrote Kara Link, a PhD candidate at the University of Washington, Seattle, and colleagues in a recent study.

– Read the entire article at Practical Pain Manager.